The Naval Medical Center Portsmouth, formerly Naval Hospital Portsmouth, and originally Norfolk Naval Hospital, is a United States Navy medical center in Portsmouth, Virginia, United States. It is the oldest continuously running hospital in the Navy medical system.

During the past decade, Naval Medical Center Portsmouth conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 44 clinical trials were completed, i.e. on average, 110% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 15 clinical trials were completed. i.e. 93.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Naval Medical Center Portsmouth" #1 sponsor was "Children's Oncology Group" with 64 trials, followed by "Radiation Therapy Oncology Group" with 46 trials sponsored, "National Cancer Institute (NCI)" with 24 trials sponsored, "United States Naval Medical Center, Portsmouth" with 11 trials sponsored and "Henry M. Jackson Foundation for the Advancement of Military Medicine" with 11 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Naval Medical Center Portsmouth" #1 collaborator was "National Cancer Institute (NCI)" with 127 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "United States Naval Medical Center, Portsmouth" with 7 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials as a collaborator and "Radiation Therapy Oncology Group" with 6 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "Naval Medical Center Portsmouth" are "Prostate Cancer" (15 trials), "Leukemia" (13 trials), "Head and Neck Cancer" (12 trials), "Sarcoma" (10 trials) and "Brain and Central Nervous System Tumors" (8 trials). Many other conditions were trialed in "Naval Medical Center Portsmouth" in a lesser frequency.

Most popular intervention types in "Naval Medical Center Portsmouth" are "Drug" (131 trials), "Radiation" (85 trials), "Procedure" (56 trials), "Other" (53 trials) and "Biological" (49 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (41 trials), "Laboratory Biomarker Analysis" (26 trials), "filgrastim" (20 trials), "Cyclophosphamide" (19 trials) and "cyclophosphamide" (18 trials). Other intervention names were less common.

The vast majority of trials in "Naval Medical Center Portsmouth" are 169 trials for "All" genders, 18 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 55 active trials in "Naval Medical Center Portsmouth". 1 are not yet recruiting, 20 are recruiting, 33 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 132 completed trials in Naval Medical Center Portsmouth, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Naval Medical Center Portsmouth, 15 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 26 trials that are defined as “Not Applicable".